Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.


CSE:QNTM - Post by User

Post by DavidRosenbergon Apr 12, 2023 9:24am
170 Views
Post# 35390294

Opinion on todays news release fsd Pharma spinoff

Opinion on todays news release fsd Pharma spinoff
OK time to do some opinion on this mornings news release : 
 
FSD Pharma Announces Plan to Spin-Out  Subsidiary as Distribution to Shareholders; Shareholder Meeting  Scheduled for June 29, 2023
 
 
 
basically FSD is having a meeting on june 29th to vote upon an approval for creating a second company under FSD Pharma's wing that will also be a publicly traded company. Class A Shareholders basically have the power to do this,  It will be a separate entity i think . the name of the company is yet to be reviled it wont be called "pubco" as in the news release which is confusing legal terminology. 
 
 
 
For each FSD Pharma share that we hold you will get a free share of the spin off company. So if you have 1000 FSD Pharma shares you will get 1000 free shares of the new company which will also be trading on the stock market but as a separate entity from my understanding. 
 
 
 
You will still have your FSD Pharma shares , plus an additional amount equaling to the amount of FSD Shares that you have . 
 
 
 
So 1000 FSD Pharma shares and another free 1000 shares of the spin off company which we won't know what it is until they do the meeting and if they approve the spinoff.  
 
 
 
So you will have double shares one of FSD Pharma and another equal amount in the spinoff company which we know nothing about yet.
 
 
 
Shareholders must hold FSD Share as of the Distribution Date to qualify  to receive shares of Pubco in the distribution. FSD Pharma will provide  further updates on the Distribution Date in due course.
 
 
 
Interesting developments as we go into the summer months.
 
 
 
Good luck guys
<< Previous
Bullboard Posts
Next >>